dock_to_right dock_to_right arrow_back

Terminology chevron_right Concepts chevron_right 418260004

Production

add

Component

418260004

The component that hold information about this concept.

Fully Specified Name (FSN)

Vandetanib (substance)

Shortest Term

Vandetanib

Definition Status

900000000000074008 |Necessary but not sufficient concept definition status (core metadata concept)|

Specifies if the concept version is primitive or defined. Set to a descendant of 900000000000444006

Summary

Vandetanib (substance)

SCTID: 418260004, Primitive, Active

418260004|Vandetanib (substance)|

en Vandetanib
en Vandetanib (substance)

Expression

418260004 |Vandetanib (substance)|
 <<< 734578001 |Angiogenesis inhibitor (disposition)| + 
734581006 |Protein-tyrosine kinase inhibitor (disposition)| + 
786911005 |Vascular endothelial growth factor receptor antagonist (disposition)| + 
734625009 |Epidermal growth factor receptor antagonist (disposition)| + 
406760002 |Quinazoline (substance)| + 
409408008 |Angiogenesis inhibitor (substance)| + 
372521009 |Piperidine derivative (substance)| + 
372917005 |Protein-tyrosine kinase inhibitor (substance)| + 
786910006 |Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)| + 
409402009 |Substance with epidermal growth factor receptor antagonist mechanism of action (substance)|

Diagram

Active

Component help	Language Code help	Type	Term help	Case Significance help	Acceptability	Active
2579008013 - Vandetanib (en) View
2579008013	en	Synonym (core metadata concept)	Vandetanib	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	True
2575565012 - Vandetanib (substance) (en) View
2575565012	en	Fully specified name (core metadata concept)	Vandetanib (substance)	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	True

Type help	Destination help	Relationship group help	Characteristic type help	Active
Relationship (9335056025) - 418260004 -> 407312007 (116680003) View
116680003 \|Is a (attribute)\|	407312007 \|Enzyme inhibitor (substance)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	False
Relationship (9561494029) - 418260004 -> 372688009 (116680003) View
116680003 \|Is a (attribute)\|	372688009 \|Antineoplastic agent (substance)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	False
Relationship (13191346029) - 418260004 -> 786911005 (726542003) View
726542003 \|Has disposition (attribute)\|	786911005 \|Vascular endothelial growth factor receptor antagonist (disposition)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (13191347022) - 418260004 -> 786910006 (116680003) View
116680003 \|Is a (attribute)\|	786910006 \|Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (13191348028) - 418260004 -> 409402009 (116680003) View
116680003 \|Is a (attribute)\|	409402009 \|Substance with epidermal growth factor receptor antagonist mechanism of action (substance)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (13191349020) - 418260004 -> 734625009 (726542003) View
726542003 \|Has disposition (attribute)\|	734625009 \|Epidermal growth factor receptor antagonist (disposition)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (9308950024) - 418260004 -> 312414008 (116680003) View
116680003 \|Is a (attribute)\|	312414008 \|Chemical categorized functionally (substance)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	False
Relationship (7653326029) - 418260004 -> 734578001 (726542003) View
726542003 \|Has disposition (attribute)\|	734578001 \|Angiogenesis inhibitor (disposition)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (7653327022) - 418260004 -> 734581006 (726542003) View
726542003 \|Has disposition (attribute)\|	734581006 \|Protein-tyrosine kinase inhibitor (disposition)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (2848858025) - 418260004 -> 406760002 (116680003) View
116680003 \|Is a (attribute)\|	406760002 \|Quinazoline (substance)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (2848859022) - 418260004 -> 409408008 (116680003) View
116680003 \|Is a (attribute)\|	409408008 \|Angiogenesis inhibitor (substance)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (2848860028) - 418260004 -> 372521009 (116680003) View
116680003 \|Is a (attribute)\|	372521009 \|Piperidine derivative (substance)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (2848861029) - 418260004 -> 372917005 (116680003) View
116680003 \|Is a (attribute)\|	372917005 \|Protein-tyrosine kinase inhibitor (substance)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True

Fully Specified Name (FSN)	Shortest Term	Definition Status help	Active
786910006 View
786910006	Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)	Vegf antagonist	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
786911005 View
786911005	Vascular endothelial growth factor receptor antagonist (disposition)	Vegf antagonist	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True
372917005 View
372917005	Protein-tyrosine kinase inhibitor (substance)	Protein-tyrosine kinase inhibitor	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
409402009 View
409402009	Substance with epidermal growth factor receptor antagonist mechanism of action (substance)	Egfr inhibitor	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
409408008 View
409408008	Angiogenesis inhibitor (substance)	Angiogenesis inhibitor	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
734578001 View
734578001	Angiogenesis inhibitor (disposition)	Angiogenesis inhibitor	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True
734581006 View
734581006	Protein-tyrosine kinase inhibitor (disposition)	Protein-tyrosine kinase inhibitor	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True
734625009 View
734625009	Epidermal growth factor receptor antagonist (disposition)	Egfr antagonist	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True
406760002 View
406760002	Quinazoline (substance)	Quinazoline	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True
372521009 View
372521009	Piperidine derivative (substance)	Piperidine derivative	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True

Fully Specified Name (FSN)	Shortest Term	Definition Status help	Active

Reference Set help	Map Target help	Map Rule help	Map Advice help	Correlation help	Map Category help

Terminology chevron_right Concepts chevron_right 418260004

Descriptions

Relationships

Parent Concepts

Children Concepts

Extended Maps

Recent searches